• Our Business Strategies are:

  • 1) To sell or license a high expressing stable protein or antibody producing cell lines to Pharmaceutical companies.

    2) To develop cell lines under contractual agreement for Pharmaceutical companies.

    3) To co-develop Biosimilar drugs with other Pharmaceutical companies for commercialization.

    4) To develop high producing stably expressing protein cell lines or antibody producing cell lines of your interest.

    5) To produce antibody or protein, purify them and provide the purified material for your studies.